The New York Times article discusses how Terray Therapeutics is leveraging AI to revolutionize drug discovery. Using advanced AI models and vast data sets, Terray aims to speed up the development of new drugs by predicting how potential drug molecules will interact with biological targets, significantly reducing the time and cost associated with traditional drug discovery methods. This approach enables more efficient identification of promising drug candidates, which is crucial in developing effective treatments for various diseases, including cancer (SciTechDaily) (NVIDIA Blog). For more detailed information, you can read the full article on the New York Times website.
Leave a Reply